Is Avanos Medical Inc (AVNS) overvalued? · rev $687.8M
Avanos Medical Inc (AVNS) is a medical devices company listed on NYSE.
This page asks whether Avanos Medical Inc (AVNS) looks expensive on cached numbers — not a short thesis.
Latest reported AVNS revenue for 2024-12-31 was $687.8M. Net income was -$392.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. AVNS currently screens at market cap $1.17B.
AVNS currently screens at market cap $1.17B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AVNS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AVNS stock page for the full model, not this heading.
Not investment advice.